The Hospital Universitario La Paz, HULP, is a general tertiary hospital situated in the neighbourhood that takes its name from the hospital in the northern city district of Fuencarral-El Pardo in the city of Madrid in Spain.

There are 1,308 beds in Hospital Universitario La Paz - PPDS.

During the past decade, Hospital Universitario La Paz - PPDS conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario La Paz - PPDS" #1 sponsor was "Shire" with 5 trials, followed by "Takeda" with 5 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored, "Agios Pharmaceuticals, Inc." with 1 trials sponsored and "Enanta Pharmaceuticals, Inc" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Paz - PPDS" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator and "BeiGene, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Paz - PPDS" are "Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials), "Migraine" (2 trials), "Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Anemia, Sickle Cell" (1 trials). Many other conditions were trialed in "Hospital Universitario La Paz - PPDS" in a lesser frequency.

Most popular intervention types in "Hospital Universitario La Paz - PPDS" are "Drug" (20 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ontamalimab" (3 trials), "Cisplatin" (2 trials), "Eptinezumab" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario La Paz - PPDS" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitario La Paz - PPDS". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Universitario La Paz - PPDS, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario La Paz - PPDS, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".